Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -1.1% | +10.8% | 1 / 3 | -14.6% | +7.22 pp | +0.37 pp | +6.5% | 0.49 | 11.55 | 1.176 | −14,6% | 31,7 | −1,1% | 11.55 | 10.81 | +6,9% |
| Pts | 0 | 0 | 4 | 0 | 12 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 9.340 (close price on 2026-10-19)EPS (TTM): 808,6
Financial charts
1.Revenue & growth
VND bn1.176Q2/26
1.Revenue & growth
VND bn1.176Q2/26
2.Profit & growth
VND bn31,8Q2/26
3.Profit mix (Penman)
VND bn159Q2/26
4.Margins & cost structure
%16.6%Q2/26
5.Returns & cash cycle
% · days5.7%Q2/26
6.Earnings quality & cash
VND bn355Q2/26
7.Asset structure
VND bn3.611Q2/26
8.Funding & debt health
VND bn · times3.611Q2/26
9.Revenue backlog
VND bn72,1Q2/26
10.Valuation
times · %11,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %206Q2/26
Adjusted EPS growth, latest quarter
-0.8%
Average adjusted EPS growth, 3 quarters
10.9%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26